Skip to main content
. 2014 Jun 13;5(14):5209–5217. doi: 10.18632/oncotarget.2101

Figure 3. NY-ESO-1 expression in matched primary and metastatic specimens.

Figure 3

Box plots show NY-ESO-1 expression in matched primary and metastatic specimens from the same patients. Metastatic specimens have significantly higher NY-ESO-1 expression than the primary specimens (p=0.0018).